Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNTY
5501
DELISTED
Guaranty Bancshares
GNTY
| $93K | ﹤0.01% |
3,381
+2,173
| +180% | +$62.8K |
|
5502
Investar Holding Corp
ISTR
$416M
| $93K | ﹤0.01% |
3,481
+2,832
| +436% | +$77K |
|
5503
Lineage Cell Therapeutics
LCTX
$281M
| $93K | ﹤0.01% |
45,491
+31,940
| +236% | +$67.1K |
|
5504
PUT
Oshkosh
OSK
$9.63B
| $93K | ﹤0.01% |
1,300
+900
| +225% | +$64.8K |
|
5505
Shore Bancshares
SHBI
$799M
| $93K | ﹤0.01% |
5,204
+3,410
| +190% | +$64.4K |
|
5506
CALL
Titan Machinery
TITN
$445M
| $93K | ﹤0.01% |
6,000
+4,700
| +362% | +$74.3K |
|
5507
PUT
Unilever
UL
$134B
| $93K | ﹤0.01% |
1,511
-1,245
| -45% | -$78.5K |
|
|
TBNK
5508
DELISTED
Territorial Bancorp Inc.
TBNK
| $93K | ﹤0.01% |
3,149
+2,380
| +309% | +$71.9K |
|
|
AINC
5509
DELISTED
Ashford Inc.
AINC
| $93K | ﹤0.01% |
1,230
+1,174
| +2,096% | +$97.1K |
|
|
MGI
5510
DELISTED
MoneyGram International, Inc. New
MGI
| $93K | ﹤0.01% |
17,414
-82,186
| -83% | -$516K |
|
|
ATHX
5511
DELISTED
Athersys, Inc. Common Stock
ATHX
| $93K | ﹤0.01% |
1,781
+1,449
| +436% | +$71.9K |
|
|
CVON
5512
DELISTED
ConvergeOne Holdings, Inc. Class A Common Stock
CVON
| $93K | ﹤0.01% |
9,940
+8,126
| +448% | +$76K |
|
|
BBU
5513
DELISTED
Brookfield Business Partners
BBU
| $92K | ﹤0.01% |
3,116
-597
| -16% | -$15.9K |
|
|
BFIN
5514
DELISTED
BankFinancial
BFIN
| $92K | ﹤0.01% |
5,820
+4,488
| +337% | +$74K |
|
5515
CALL
Brookdale Senior Living
BKD
$3.04B
| $92K | ﹤0.01% |
9,400
-700
| -7% | -$6.44K |
|
5516
CALL
Popular Inc
BPOP
$11.2B
| $92K | ﹤0.01% |
1,800
-33,900
| -95% | -$1.69M |
|
5517
PUT
Commercial Metals
CMC
$8.04B
| $92K | ﹤0.01% |
4,500
-300
| -6% | -$6.46K |
|
5518
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
| $92K | ﹤0.01% |
578
-67
| -10% | -$10.1K |
|
|
FPI
5519
Farmland Partners
FPI
$427M
| $92K | ﹤0.01% |
13,618
+10,946
| +410% | +$75.1K |
|
|
MRSN
5520
DELISTED
Mersana Therapeutics
MRSN
| $92K | ﹤0.01% |
367
+262
| +250% | +$87.8K |
|
5521
CALL
Myriad Genetics
MYGN
$308M
| $92K | ﹤0.01% |
2,000
-10,300
| -84% | -$458K |
|
5522
Radiant Logistics
RLGT
$390M
| $92K | ﹤0.01% |
15,626
+12,745
| +442% | +$56.1K |
|
|
TEF
5523
PUT
DELISTED
Telefonica
TEF
| $92K | ﹤0.01% |
14,480
| – | – |
|
|
MSL
5524
DELISTED
Midsouth Bancorp, Inc.
MSL
| $92K | ﹤0.01% |
5,995
+4,751
| +382% | +$69.8K |
|
5525
PUT
Cheniere Energy
CQP
$33B
| $91K | ﹤0.01% |
2,300
+1,500
| +188% | +$56.7K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.